The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of stratifying levels of serum lactate dehydrogenase (LDH) at diagnosis on the overall survival (OS) in newly diagnosed multiple myeloma (NDMM).
 
Laura Evans
No Relationships to Disclose
 
Shaji Kumar
Consulting or Advisory Role - Abbvie (Inst); Abbvie (Inst); Amgen (Inst); Bluebird Bio (Inst); Celgene (Inst); Cellectar; Genecentrix; Genentech/Roche (Inst); Janssen Oncology (Inst); Kite, a Gilead company (Inst); Merck (Inst); Molecular Partners (Inst); Oncopeptides; Takeda (Inst)
Research Funding - Abbvie (Inst); CARsgen Therapeutics (Inst); Celgene (Inst); Janssen Oncology (Inst); Kite, a Gilead company (Inst); MedImmune (Inst); Merck (Inst); Novartis (Inst); Roche/Genentech (Inst); Sanofi (Inst); Takeda (Inst); TeneoBio (Inst)
 
David Dingli
No Relationships to Disclose
 
Angela Dispenzieri
Consulting or Advisory Role - Janssen Research & Development
Research Funding - Alnylam (Inst); Celgene (Inst); Janssen Oncology (Inst); Pfizer (Inst); Prothena; Takeda (Inst)
Travel, Accommodations, Expenses - Janssen Oncology; Pfizer; Prothena
 
Martha Lacy
No Relationships to Disclose
 
Ronald S. Go
No Relationships to Disclose
 
Francis Buadi
No Relationships to Disclose
 
Nelson Leung
No Relationships to Disclose
 
Yi Lin
Consulting or Advisory Role - Bluebird Bio (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Gamida Cell (Inst); Janssen Oncology (Inst); Juno Therapeutics (Inst); Kite/Gilead (Inst); Legend Biotech (Inst); Novartis (Inst); Sorrento Therapeutics (Inst); Vineti (Inst)
Research Funding - Bluebird Bio (Inst); Boston Scientific (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Janssen Oncology (Inst); Kite/Gilead (Inst); Merck (Inst); Takeda (Inst)
 
Suzanne R. Hayman
No Relationships to Disclose
 
Stephen J. Russell
Stock and Other Ownership Interests - Imanis Life Sciences; Vyriad
Patents, Royalties, Other Intellectual Property - As a Mayo Clinic employee I have filed invention disclosures and some of those have been filed as patents. I have assigned my rights in those patents to Mayo Clinic. (Inst)
Travel, Accommodations, Expenses - Vyriad
 
Eli Muchtar
No Relationships to Disclose
 
Prashant Kapoor
Honoraria - BeiGene; Cellectar; Clinical Care Options; GlaxoSmithKline (Inst); Karyopharm Therapeutics; Pharmacyclics; Sanofi (Inst)
Consulting or Advisory Role - Sanofi (Inst)
Research Funding - Abbvie (Inst); Amgen (Inst); GlaxoSmithKline (Inst); Karyopharm Therapeutics (Inst); Regeneron (Inst); Sanofi (Inst); Sorrento Therapeutics (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline; Janssen; Sanofi
 
Mustaqeem Ahmad Siddiqui
No Relationships to Disclose
 
Rahma M. Warsame
No Relationships to Disclose
 
Taxiarchis Kourelis
No Relationships to Disclose
 
Robert A. Kyle
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Pfizer; Pharmacyclics
 
Morie A. Gertz
No Relationships to Disclose
 
S. Vincent Rajkumar
No Relationships to Disclose
 
Wilson I. Gonsalves
No Relationships to Disclose